Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (DRKS00038014) titled 'Expert interviews with professionals from healthcare research and design as well as from healthcare practice on barriers, facilitators, good practices and recommendations for action in cancer screening for people with intellectual disabilities as part of the EUCanScreen Joint Action' on Oct. 1.
Study Type: observational
Study Design:
Allocation:
Masking:
Control:
Assignment:
Study design purpose: screening
Primary Sponsor: Deutsche Krebsgesellschaft e. V.
Condition:
People with intellectual disabilities according to ICD-10 (F70-F79). In addition, syndromes associated with ID are included, such as Rett syndrome (...